{"news_desk": "Business", "print_page": "1", "section_name": "Business Day", "subsection_name": null, "byline": {"contributor": "", "original": "By ANDREW POLLACK", "person": [{"rank": 1, "role": "reported", "firstname": "Andrew", "organization": "", "lastname": "POLLACK"}]}, "abstract": "Several patient advocacy groups have emerged as unlikely opponents of California ballot initiative aimed at reducing prescription drug prices; say plan will be difficult to implement and could inadvertently lead to higher prices as pharmaceutical companies seek to outmaneuver restrictions. ", "type_of_material": "News", "word_count": "1324", "lead_paragraph": "A California initiative meant to lower skyrocketing prescription drug prices faces opposition from not only drug makers but also some patient advocacy groups.", "pub_date": "2016-07-05T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "California Drug Price Plan Is Criticized by Patient Advocates", "print_headline": "Drug Price Plan Has Surprising Opposition"}, "snippet": "A California initiative meant to lower skyrocketing prescription drug prices faces opposition from not only drug makers but also some patient advocacy groups....", "multimedia": [{"height": 126, "url": "images/2016/06/30/business/01DRUGS/01DRUGS-thumbWide.jpg", "legacy": {"widewidth": "190", "wideheight": "126", "wide": "images/2016/06/30/business/01DRUGS/01DRUGS-thumbWide.jpg"}, "type": "image", "width": 190, "subtype": "wide"}, {"height": 399, "url": "images/2016/06/30/business/01DRUGS/01DRUGS-articleLarge.jpg", "legacy": {"xlargewidth": "600", "xlargeheight": "399", "xlarge": "images/2016/06/30/business/01DRUGS/01DRUGS-articleLarge.jpg"}, "type": "image", "width": 600, "subtype": "xlarge"}, {"height": 75, "url": "images/2016/06/30/business/01DRUGS/01DRUGS-thumbStandard.jpg", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2016/06/30/business/01DRUGS/01DRUGS-thumbStandard.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "subtype": "thumbnail"}], "web_url": "http://www.nytimes.com/2016/07/05/business/california-drug-price-plan-is-criticized-by-patient-advocates.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "2", "is_major": "N", "value": "Prices (Fares, Fees and Rates)", "name": "subject"}, {"rank": "3", "is_major": "Y", "value": "California", "name": "glocations"}, {"rank": "4", "is_major": "Y", "value": "Referendums", "name": "subject"}, {"rank": "5", "is_major": "N", "value": "Health Insurance and Managed Care", "name": "subject"}], "blog": [], "_id": "577ad2f738f0d83e1f65d6e2", "source": "The New York Times"}